Law enforcement agencies have traditionally focused on the destruction of crops and production facilities, the interdiction of supply lines and the arrest and punishment of consumers. This approach has often exacerbated the worst aspects of the market (violence, ill health, social marginalisation of users, etc.). Some authorities have recently changed their approach, seeking to manage the market in a way that minimises its associated harms.
The new Secretary-General, Antonio Guterres, pushed for decriminalisation of use of all drugs for personal consumption when he was Prime Minister of Portugal. Could he introduce his comprehensive strategy to reduce drug-related harm on the international stage?
This study aims to provide evidence on international and EU approaches to drug policy, including emerging challenges and focusing on several case study countries. This evidence has been used to identify and develop policy proposals.
A new study in Lancet Global Health reveals that opioid-dependent individuals in compulsory drug treatment were significantly more likely to relapse to opioid use after release than opioid-dependent individuals receiving methadone in voluntary treatment centres.
As NPS have entered the markets at an unprecedented rate, legislation has been unable to keep pace. This report for policymakers and legal practioners, from the EMCDDA and Eurojust, aims to outline the challenges and paths forward in NPS regulation.
This study of retail prices of cocaine and opiates in Portugal following drug decriminalization shows that softer drug law enforcement does not necessarily lead to lower prices, which in the Portuguese case may be explained by a more efficient use of resources to fight drug trafficking.
In the video, an international panel of artists discuss their work promoting drug policy reform and illustrate how prohibitionist drug policies impact marginalized communities in the United States and abroad.